NURS reports record Q2 revenue and profit; upbeat H2 outlook
NURS said record Q2 revenue and profit reflected broad-based growth across all segments, with pharmacy and direct-to-consumer platform expansion. Regulatory changes and structural investments are cited for accelerated second-half growth.
Record Q2 revenue and profit were driven by broad-based growth across all segments, with significant expansion in pharmacy and direct-to-consumer platforms.
Regulatory changes and structural investments position the business for accelerated growth in the second half.Based on Hydreight Technologies…